Fierce Pharma

JULY 14, 2023

As Johnson & Johnson awaits a decision on its second attempt to resolve talc lawsuits through a bankruptcy ploy, the company is attempting another legal tactic to free itself from those liabili | As Johnson & Johnson awaits a decision on its second attempt to resolve talc lawsuits through a bankruptcy ploy, the company is attempting another legal tactic to help free itself from those liabilities—suing doctors who say that its iconic baby powder can cause cancer.

Doctors 215

Doctors 215

MedCity News

JULY 14, 2023

Inflammation and immunology biotech Apogee Therapeutics and Sagimet Biosciences, a company developing a drug for the fatty liver disease NASH, are the latest biotech companies to join the public markets. Both companies upsized their IPOs, raising cash for clinical trials.

Marketing 94

Marketing Biopharma Pharma 94

Fierce Pharma

JULY 14, 2023

The potentially curative promise of gene therapies often carries a steep price tag. | The potentially curative promise of gene therapies often carries a steep price tag. But for a pair of personalized medicine prospects in sickle cell disease (SCD), the cost could be worth it, at least as far as ICER is concerned.

Prospecting 205

Prospecting Medicine 205

MedCity News

JULY 14, 2023

For those unfamiliar with the CPAP recall situation in question, imagine if one-third of all cars on the road were suddenly recalled for potentially life-threatening issues. Now imagine that in the aforementioned hypothetical automobile recall, the media dedicated its energy almost entirely to reporting on the worsening problem without making viewers aware of potential solutions.

Media 93

Media Medical 93

Advertisement

Distribution

Fierce Pharma

JULY 14, 2023

In June of last year, after Mallinckrodt Pharmaceuticals emerged from a Chapter 11 reorganization and agreed to a $1.

Pharmaceutical 153

Pharmaceutical 153

MedCity News

JULY 14, 2023

CMS recently revealed its proposals to raise reimbursement rates for hospital outpatient departments and cut payments for physicians. Next year, the agency is planning to decrease physicians’ pay by 1.25% and increase outpatient payment rates by 2.8%. Provider groups are unhappy with the news — AMA President Dr. Jesse Ehrenfeld said the new physician fee schedule will be “almost biblical in its impact.

Physicians 85

Physicians Medical 85

Copyright Clearance Center

JULY 14, 2023

Copyright infringement lawsuits from authors and artists against creators of Generative AI software are mounting.

98

98

MedCity News

JULY 14, 2023

Health Net is making a $46 million investment that will be spread out across 26 counties in California, and will support Continuum of Care programs, which are regional or local planning bodies that help those experiencing homelessness find housing and other services.

75

75

PharmaTimes

JULY 14, 2023

CAR-T cell therapy being researched among patients with relapsed or refractory B cell non-Hodgkin lymphoma - News - PharmaTimes

Patients 87

Patients 87

Medgadget

JULY 14, 2023

Researchers at the University of Birmingham in the UK have developed a wearable that can assist in keeping track of stress hormone levels in the body over time. Disregulated stress hormones can play a role in various disease states, from heart disease to depression. However, until now, researchers had to perform blood draws to measure stress hormone levels, meaning that they could obtain just one snapshot in time of hormone levels or repeated blood draws over time, neither of which are ideal.

Medicine 69

Medicine Doctors Patients 69

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTimes

JULY 14, 2023

Collaboration will focus on progressing test for early detection of Alzheimer’s dementia - News - PharmaTimes

81

81

Medgadget

JULY 14, 2023

Researchers at the University of Washington have developed an app that converts common smartphones into clinical thermometers. Spotting the signs of fever early could make a difference in providing early treatment or beginning a period of isolation to reduce the chance of disease transmission. This is particularly important for viral diseases, such as COVID-19.

Medicine 67

Medicine 67

Eversana Intouch

JULY 14, 2023

The Urgent Need for Action Climate scientists and activists have been tirelessly working to sound the alarm on climate change and its impacts, but despite their efforts, meaningful intervention is too slow in coming. Climate change and health inequities demand immediate attention, and pharma advertisers are uniquely positioned to drive change. Most of us who work in pharma advertising do so because we believe we can make a difference.

Pharma 52

Pharma Food Healthcare Healthcare 52

Pharmaceutical Commerce

JULY 14, 2023

Recent data and commentary offer insights into how biologics vs. small molecule patent protections under the Inflation Reduction Act pricing scenarios is impacting investing in the biotech sector.

52

52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Legacy MEDSearch

JULY 14, 2023

AlloSource ® , one of the largest allograft providers creating innovative cellular and tissue products to help surgeons heal their patients, today announced the U.S. Food and Drug Administration’s 510(K) clearance of AceConnex Pre-Sutured Fascia for hip labral reconstruction and augmentation. This product reinforces AlloSource’s commitment to providing innovative products to support the overall sports medicine market, including hip arthroscopy. “AceConnex Pre-Sutured Fascia was

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Pharmaceutical Technology

JULY 14, 2023

Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.

Patients 52

Patients 52

PharmaTech

JULY 14, 2023

German manufacturer metabion is conducting a multi-million euro expansion of its oligonucleotide manufacturing capacity in Munich East.

Manufacturing 52

Manufacturing 52

Pharmaceutical Technology

JULY 14, 2023

Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.

Networking 52

Networking 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmacy Times

JULY 14, 2023

Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.

49

49

Pharmaceutical Technology

JULY 14, 2023

AstraZeneca and Merck have received conditional approval from Health Canada for Lynparza (olaparib) combination to treat prostate cancer.

52

52

Pharmacy Times

JULY 14, 2023

Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular lymphoma.

FDA 49

FDA Patients 49

Pharmaceutical Technology

JULY 14, 2023

Theseus Pharmaceuticals has terminated its pan-variant tyrosine kinase receptor (KIT) inhibitor (THE-630) drug development programme.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharmaceutical Commerce

JULY 14, 2023

Ruling validates antitrust theory, pushes antitrust arbitration against Prime Therapeutics forward.

52

52

Pharmaceutical Technology

JULY 14, 2023

Emmaus Life Sciences has received marketing authorisation for Endari (L-glutamine oral powder) in Oman for sickle cell disease.

Marketing 52

Marketing 52

PharmaVoice

JULY 14, 2023

With major projects brewing at both organizations, these new leaders will hit the ground running.

52

52

Pharmaceutical Technology

JULY 14, 2023

The offering follows recent lucrative deals with Novartis and Bayer for the use of Bicycle Therapeutics’ peptide technology.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Nixon Gwilt Law

JULY 14, 2023

The Centers for Medicare & Medicaid Services (“CMS”) released its much-anticipated Proposed Medicare Physician Fee Schedule for CY 2024 (the “Proposed Rule”) on July 13, 2023. This year’s Proposed Rule came later than usual, likely because it includes significant changes and clarifications around how services will be provided going forward since the COVID-19 Public Health Emergency (“PHE”) came to an end on May 11th.

Physicians 40

Physicians Management Patients Education 40

Pharmaceutical Technology

JULY 14, 2023

Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.

Pharmaceutical 52

Pharmaceutical 52

Pharma Marketing Network

JULY 14, 2023

The post Michael Rowbotham appeared first on Pharma Marketing Network.

Networking 52

Networking Pharma Marketing 52

Pharmaceutical Technology

JULY 14, 2023

Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s price tag of $6,922 for the same quantity.

Sales 52

Sales 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management